References
- Dursun D, Akta,s S, Altun Z, Olgun N. Bilateral breast cancer with neurofibromatosis type 1 patient: case report. Eur J Breast Health 2017;13:213-215 https://doi.org/10.5152/ejbh.2017.3105
- Seo YN, Park YM. Association between neurofibromatosis type 1 and breast cancer: a report of two cases with a review of the literature. Case Rep Med 2015;2015:456205
- Kim SH, Son WJ, Sin DJ, Chang MC. Bilateral metachronous breast cancer in neurofibromatosis type 1. J Korean Surg Soc 2009;76:388-391 https://doi.org/10.4174/jkss.2009.76.6.388
- Alamsamimi M, Mirkheshti N, Mohajery MR, Abdollahi M. Bilateral invasive ductal carcinoma in a woman with neurofibromatosis type 1. Arch Iran Med 2009;12:412-414
- Bonnet SE, Kang-Chapman JK, Buckley KA, Cui X, Grignol VP, Hawley JR. Malignant peripheral nerve sheath tumor of the breast in a patient with neurofibromatosis 1. Breast J 2018;24:1066-1068 https://doi.org/10.1111/tbj.13127
- Maani N, Westergard S, Yang J, Scaranelo AM, Telesca S, Thain E, et al. NF1 patients receiving breast cancer screening: insights from the Ontario high risk breast screening program. Cancers (Basel) 2019;11:707
- Sharif S, Moran A, Huson SM, Iddenden R, Shenton A, Howard E, et al. Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening. J Med Genet 2007;44:481-484 https://doi.org/10.1136/jmg.2007.049346
- Madanikia SA, Bergner A, Ye X, Blakeley JO. Increased risk of breast cancer in women with NF1. Am J Med Genet A 2012;158A:3056-3060 https://doi.org/10.1002/ajmg.a.35550
- Shuayb M, Begum R. Unusual primary breast cancer - malignant peripheral nerve sheath tumor: a case report and review of the literature. J Med Case Rep 2017;11:161
- Yap YS, Munusamy P, Lim C, Chan CHT, Prawira A, Loke SY, et al. Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype. Breast Cancer Res Treat 2018;171:719-735 https://doi.org/10.1007/s10549-018-4851-6